v3.26.1
Note 6 - Earnings Per Common Share
9 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 6 - EARNINGS PER COMMON SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding:

 

(in thousands, except per share data)

 

Three Months Ended

  

Nine Months Ended

 
  

March 31,

  

March 31,

 
  

2026

  

2025

  

2026

  

2025

 
                 

BASIC EARNINGS PER SHARE

                
                 

Net Income

 $2,091  $3,883  $15,703  $16,212 
                 

Weighted average shares outstanding during the period, net of treasury shares

  31,836   28,904   30,390   28,754 
                 

Weighted average vested restricted stock units outstanding

  82   71   62   78 
                 

Weighted average shares outstanding in the Deferred Compensation Plan during the period

  1,100   1,028   1,079   1,009 

Weighted average shares outstanding

  33,018   30,003   31,531   29,841 
                 

Basic income per share

 $0.06  $0.13  $0.50  $0.54 
                 

DILUTED EARNINGS PER SHARE

                
                 

Net Income

 $2,091  $3,883  $15,703  $16,212 
                 

Weighted average shares outstanding

                
                 

Basic

  33,018   30,003   31,531   29,841 
                 

Effect of dilutive securities (a):

                

Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any

  837   963   856   949 

Weighted average shares outstanding

  33,855   30,966   32,387   30,790 
                 

Diluted income per share

 $0.06  $0.13  $0.48  $0.53 
                 

Anti-dilutive securities (b)

  3   35   2   265 

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded from the computation of diluted net income per share for the three and nine months ended March 31, 2026, and March 31, 2025, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.